Yan Rachel E, Corman Alba, Katgara Lyla, Wang Xiao, Xue Xinhe, Gajic Zoran Z, Sam Richard, Farid Michael, Friedman Samuel M, Choo Jungwook, Raimondi Ivan, Ganesan Shridar, Katsevich Eugene, Greenfield Jeffrey P, Dahmane Nadia, Sanjana Neville E
New York Genome Center, New York, NY, USA.
Department of Biology, New York University, New York, NY, USA.
Nat Biotechnol. 2024 Nov 21. doi: 10.1038/s41587-024-02475-x.
Pooled single-cell CRISPR screens have profiled either gene expression or chromatin accessibility but not both modalities. Here we develop MultiPerturb-seq, a high-throughput CRISPR screening platform with joint single-nucleus chromatin accessibility, transcriptome and guide RNA capture using combinatorial indexing combined with droplet microfluidics to scale throughput and integrate all three modalities. We identify key differentiation genes in a rare pediatric cancer and establish ZNHIT1 as a potential target for cancer reprogramming therapy.
Nat Biotechnol. 2024-11-21
Nat Biotechnol. 2020-3-30
Nat Methods. 2017-3
Nat Biotechnol. 2019-6-24
Nat Protoc. 2022-6
Nat Biotechnol. 2022-3
Genome Res. 2021-10
BMC Bioinformatics. 2021-9-10